-+ 0.00%
-+ 0.00%
-+ 0.00%

Vanderbilt Health to conduct clinical trial of HMBD-002-PER.AX

ASX·08/27/2026 22:11:20

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.